Logo image of BODI

BEACHBODY CO INC/THE (BODI) Stock Fundamental Analysis

USA - NASDAQ:BODI - US0734633094 - Common Stock

5.45 USD
+0.27 (+5.21%)
Last: 10/20/2025, 8:00:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BODI. BODI was compared to 77 industry peers in the Diversified Consumer Services industry. BODI has a bad profitability rating. Also its financial health evaluation is rather negative. BODI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BODI has reported negative net income.
In the past year BODI had a positive cash flow from operations.
In the past 5 years BODI always reported negative net income.
In multiple years BODI reported negative operating cash flow during the last 5 years.
BODI Yearly Net Income VS EBIT VS OCF VS FCFBODI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

The Return On Assets of BODI (-39.90%) is worse than 76.62% of its industry peers.
BODI has a Return On Equity of -288.76%. This is in the lower half of the industry: BODI underperforms 79.22% of its industry peers.
Industry RankSector Rank
ROA -39.9%
ROE -288.76%
ROIC N/A
ROA(3y)-46.66%
ROA(5y)-36.36%
ROE(3y)-176.86%
ROE(5y)-122.28%
ROIC(3y)N/A
ROIC(5y)N/A
BODI Yearly ROA, ROE, ROICBODI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

BODI has a better Gross Margin (70.02%) than 83.12% of its industry peers.
BODI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for BODI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y-1.01%
BODI Yearly Profit, Operating, Gross MarginsBODI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

BODI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BODI has more shares outstanding
Compared to 5 years ago, BODI has less shares outstanding
The debt/assets ratio for BODI is higher compared to a year ago.
BODI Yearly Shares OutstandingBODI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BODI Yearly Total Debt VS Total AssetsBODI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

BODI has an Altman-Z score of -4.76. This is a bad value and indicates that BODI is not financially healthy and even has some risk of bankruptcy.
BODI's Altman-Z score of -4.76 is on the low side compared to the rest of the industry. BODI is outperformed by 77.92% of its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that BODI has dependencies on debt financing.
BODI's Debt to Equity ratio of 1.16 is on the low side compared to the rest of the industry. BODI is outperformed by 62.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z -4.76
ROIC/WACCN/A
WACC10.32%
BODI Yearly LT Debt VS Equity VS FCFBODI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

BODI has a Current Ratio of 0.60. This is a bad value and indicates that BODI is not financially healthy enough and could expect problems in meeting its short term obligations.
BODI's Current ratio of 0.60 is on the low side compared to the rest of the industry. BODI is outperformed by 77.92% of its industry peers.
A Quick Ratio of 0.48 indicates that BODI may have some problems paying its short term obligations.
With a Quick ratio value of 0.48, BODI is not doing good in the industry: 80.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.48
BODI Yearly Current Assets VS Current LiabilitesBODI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.99% over the past year.
BODI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.97%.
The Revenue for BODI have been decreasing by -11.14% on average. This is quite bad
EPS 1Y (TTM)42.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.7%
Revenue 1Y (TTM)-31.97%
Revenue growth 3Y-21.74%
Revenue growth 5Y-11.14%
Sales Q2Q%-41.97%

3.2 Future

BODI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.75% yearly.
Based on estimates for the next years, BODI will show a very negative growth in Revenue. The Revenue will decrease by -25.27% on average per year.
EPS Next Y72.98%
EPS Next 2Y32.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-40.64%
Revenue Next 2Y-25.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BODI Yearly Revenue VS EstimatesBODI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
BODI Yearly EPS VS EstimatesBODI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BODI. In the last year negative earnings were reported.
Also next year BODI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BODI Price Earnings VS Forward Price EarningsBODI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

98.70% of the companies in the same industry are more expensive than BODI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.85
BODI Per share dataBODI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as BODI's earnings are expected to grow with 32.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.75%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BODI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEACHBODY CO INC/THE

NASDAQ:BODI (10/20/2025, 8:00:01 PM)

5.45

+0.27 (+5.21%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners40.03%
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner Change-1.32%
Market Cap38.53M
Analysts80
Price Target8.67 (59.08%)
Short Float %5.7%
Short Ratio10.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.74%
Min EPS beat(2)14.53%
Max EPS beat(2)42.94%
EPS beat(4)3
Avg EPS beat(4)7.78%
Min EPS beat(4)-77.42%
Max EPS beat(4)51.05%
EPS beat(8)4
Avg EPS beat(8)-3.9%
EPS beat(12)6
Avg EPS beat(12)-5.4%
EPS beat(16)8
Avg EPS beat(16)-9.68%
Revenue beat(2)2
Avg Revenue beat(2)8.97%
Min Revenue beat(2)7.39%
Max Revenue beat(2)10.54%
Revenue beat(4)3
Avg Revenue beat(4)5.09%
Min Revenue beat(4)-2.88%
Max Revenue beat(4)10.54%
Revenue beat(8)5
Avg Revenue beat(8)3.32%
Revenue beat(12)7
Avg Revenue beat(12)2.29%
Revenue beat(16)9
Avg Revenue beat(16)2.47%
PT rev (1m)0%
PT rev (3m)-17.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)58.26%
EPS NY rev (1m)0%
EPS NY rev (3m)36.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF 41.3
P/B 1.91
P/tB N/A
EV/EBITDA 2.85
EPS(TTM)-7.52
EYN/A
EPS(NY)-2.27
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)0.13
OCFY2.42%
SpS45.95
BVpS2.85
TBVpS-7.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.9%
ROE -288.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.02%
FCFM N/A
ROA(3y)-46.66%
ROA(5y)-36.36%
ROE(3y)-176.86%
ROE(5y)-122.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y-1.01%
F-Score5
Asset Turnover2.23
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA 1.83
Cap/Depr 10.93%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion 7.32%
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.48
Altman-Z -4.76
F-Score5
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)15.58%
Cap/Depr(5y)44.94%
Cap/Sales(3y)2.05%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.7%
EPS Next Y72.98%
EPS Next 2Y32.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.97%
Revenue growth 3Y-21.74%
Revenue growth 5Y-11.14%
Sales Q2Q%-41.97%
Revenue Next Year-40.64%
Revenue Next 2Y-25.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.3%
OCF growth 3YN/A
OCF growth 5Y-42.85%